Search filters

Authors whose works are in public domain in at least one jurisdiction

List of works by Bernd C Kieseier

A critical appraisal of treatment decisions in multiple sclerosis—old versus new ⬇️

scientific article published on 05 April 2011

A discrete-choice experiment to determine patient preferences for injectable multiple sclerosis treatments in Germany

scientific article published on 8 January 2016

A reliable in vitro model for studying peripheral nerve myelination in mouse

scientific article published on 21 January 2013

A role of peripheral myelin protein 2 in lipid homeostasis of myelinating Schwann cells

scientific article published on 21 May 2014

ADAM‐10 and ADAM‐17 in the inflamed human CNS ⬇️

scientific article published on June 1, 2003

Acute disseminated encephalomyelitis: an acute hit against the brain

scientific article

Acute disseminated encephalomyelitis: an update

scientific article

Advances in understanding and treatment of immune-mediated disorders of the peripheral nervous system

scientific article published in August 2004

Alemtuzumab: the advantages and challenges of a novel therapy in MS.

scientific article

Alteration of T cell cytokine production in PLPp-139-151-induced EAE in SJL mice by an immunostimulatory CpG Oligonucleotide ⬇️

scientific article published on May 30, 2011

Altered neuronal expression of TASK1 and TASK3 potassium channels in rodent and human autoimmune CNS inflammation

scientific article published in December 2008

An Interesting Case of Nuchal Rigidity ⬇️

scientific article published on May 1, 2011

An assay to quantify species-specific anti-JC virus antibody levels in MS patients

scientific article published on 6 February 2013

Analyses of cerebrospinal fluid in the diagnosis and monitoring of multiple sclerosis

scientific article published on 25 September 2009

Anti-JC virus antibodies in rituximab-treated patients with neuromyelitis optica spectrum disorder

scientific article published on 6 January 2015

Anti-JC-virus antibody prevalence in a German MS cohort

scientific article

Assessing walking disability in multiple sclerosis ⬇️

scientific article published on April 24, 2012

Assessment of JC virus DNA in blood and urine from natalizumab‐treated patients ⬇️

scientific article published on January 1, 2011

Atacicept: targeting B cells in multiple sclerosis ⬇️

scientific article published on July 1, 2010

Autoantibody-mediated dysfunction of sympathetic neurons in guillain-barre syndrome

scientific article published in February 2010

Autoimmune diseases of the peripheral nervous system ⬇️

scientific article published on May 18, 2011

Autoimmunity in the peripheral nervous system

scientific article published on January 2003

Bacterial flagellin and diphtheria toxin co-stimulate IL-17-producing thymocytes ⬇️

scientific article published on August 8, 2013

Biologic role of interferon beta in multiple sclerosis

scientific article published in June 2004

Biotherapeutics for the treatment of multiple sclerosis: hopes and hazards

scientific article published on 21 June 2013

CD19 as a molecular target in CNS autoimmunity

scientific article

CD34+ progenitor cells mobilized by natalizumab are not a relevant reservoir for JC virus

scientific article published on 15 November 2010

CIDP and other inflammatory neuropathies in diabetes - diagnosis and management

scientific article published on 15 September 2017

Case definition for progressive multifocal leukoencephalopathy following treatment with monoclonal antibodies ⬇️

scientific article published on July 17, 2012

Cerebrospinal fluid JC virus antibody index for diagnosis of natalizumab-associated progressive multifocal leukoencephalopathy

scientific article

Changes to anti-JCV antibody levels in a Swedish national MS cohort

scientific article published on 05 March 2013

Chemokines and chemokine receptors in inflammatory demyelinating neuropathies: a central role for IP-10.

scientific article published in April 2002

Chemotherapeutics in the treatment of multiple sclerosis ⬇️

scientific article published on September 1, 2010

Chronic inflammatory demyelinating polyneuropathy--update on pathogenesis, diagnostic criteria and therapy

scientific article

Chronic inflammatory demyelinating polyneuropathy.

scientific article

Citalopram suppresses thymocyte cytokine production ⬇️

scientific article published on July 22, 2013

Cladribine as a therapeutic option in multiple sclerosis ⬇️

scientific article published on June 1, 2011

Clinical improvement precedes lesion size regression in a severe case of acute disseminated encephalomyelitis ⬇️

scientific article published on November 21, 2012

Clinical management of multiple sclerosis and neuromyelitis optica with therapeutic monoclonal antibodies: approved therapies and emerging candidates

scientific article published on 15 December 2014

Clinical practice of analysis of anti-drug antibodies against interferon beta and natalizumab in multiple sclerosis patients in Europe: A descriptive study of test results

scientific article

Corneal confocal microscopy in chronic inflammatory demyelinating polyneuropathy

scientific article

Critical appraisal of the role of fingolimod in the treatment of multiple sclerosis

scientific article

Current disease-modifying therapies in multiple sclerosis

scientific article

Cyclo-oxygenases and prostaglandins in acute inflammatory demyelination of the peripheral nerve

scientific article published in December 2003

Defining a role for laquinimod in multiple sclerosis

scientific article

Defining the clinical course of multiple sclerosis: the 2013 revisions

scientific article

Depletion of B lymphocytes from cerebral perivascular spaces by rituximab

scientific article published on August 2009

Development and Validation of an Enzyme-Linked Immunosorbent Assay for the Detection of Binding Anti-Drug Antibodies against Interferon Beta

scientific article published on 6 July 2017

Development of oral cladribine for the treatment of multiple sclerosis

scientific article

Developmental maturation of innate immune cell function correlates with susceptibility to central nervous system autoimmunity ⬇️

scientific article published on June 3, 2013

Different effects of simvastatin and interferon beta on the proteolytic activity of matrix metalloproteinases

scientific article

Dimethyl fumarate in relapsing-remitting multiple sclerosis: rationale, mechanisms of action, pharmacokinetics, efficacy and safety

scientific article published on April 2015

Disease amelioration with tocilizumab in a treatment-resistant patient with neuromyelitis optica: implication for cellular immune responses

scientific article

Disease-modifying agents for multiple sclerosis: recent advances and future prospects

scientific article published on January 2008

Disease-modifying therapies in multiple sclerosis: an update on recent and ongoing trials and future strategies

scientific article

Effect of peginterferon beta-1a on MRI measures and achieving no evidence of disease activity: results from a randomized controlled trial in relapsing-remitting multiple sclerosis

scientific article

Emerging tumefactive multiple sclerosis after switching therapy from natalizumab to fingolimod ⬇️

scientific article published on November 1, 2012

Erythropoietin ameliorates rat experimental autoimmune neuritis by inducing transforming growth factor-β in macrophages

scientific article

Expression of antigen processing and presenting molecules by Schwann cells in inflammatory neuropathies

scientific article

Expression of the immune-tolerogenic major histocompatibility molecule HLA-G in multiple sclerosis: implications for CNS immunity

scientific article published on 25 August 2005

Fatigue, Pain, Anxiety and Depression in Guillain-Barré Syndrome and Chronic Inflammatory Demyelinating Polyradiculoneuropathy

scientific article

Fingolimod in multiple sclerosis: Mechanisms of action and clinical efficacy ⬇️

scientific article published on May 26, 2011

Fingolimod is a potential novel therapy for multiple sclerosis

scientific article published on 15 June 2010

Fingolimod promotes peripheral nerve regeneration via modulation of lysophospholipid signaling

scientific article published on 10 June 2016

Fingolimod treatment promotes regulatory phenotype and function of B cells

scientific article published on 16 January 2015

FoxP3+ regulatory T cells determine disease severity in rodent models of inflammatory neuropathies

scientific article

From bench to bedside--experimental rationale for immune-specific therapies in the inflamed peripheral nerve

scientific article published on April 2007

Glatiramer acetate attenuates pro-inflammatory T cell responses but does not directly protect neurons from inflammatory cell death

scientific article

Guillain-Barré syndrome after exposure to influenza virus ⬇️

scientific article published on September 1, 2010

Heat exposure and bicycling trigger recurrent aseptic meningitis: a case report

scientific article published on 31 December 2014

Human muscle cells express the costimulatory molecule B7-H3, which modulates muscle-immune interactions

scholarly article by Anne Waschbisch et al published November 2008 in Arthritis and Rheumatism

Humoral immune responses after rabies infection

scientific article published in September 2007

Identification and development of new therapeutics for multiple sclerosis

scientific article published on 17 September 2008

Identification of targets and new developments in the treatment of multiple sclerosis--focus on cladribine

scientific article

Immune circuitry in the peripheral nervous system

scientific article published on October 2006

Immune mechanisms in chronic inflammatory demyelinating neuropathy

scientific article

Immune regulation of multiple sclerosis

scientific article published on January 2014

Immune response to immunotherapy: the role of neutralising antibodies to interferon beta in the treatment of multiple sclerosis

scientific article

Immune-mediated neuropathies

scientific article published on 11 October 2018

Immune-mediated neuropathies.

scientific article

Immunobiology of muscle: advances in understanding an immunological microenvironment

scientific article

Immunomodulatory treatment strategies in multiple sclerosis

scientific article published on December 2008

Immunopathogenesis and immunotherapy of multiple sclerosis

scientific article published on April 2006

Immunosuppressive agents in multiple sclerosis

scientific article published on October 2007

Improvement in relapse recovery with peginterferon beta-1a in patients with multiple sclerosis

scientific article published on January 2016

Incidence of therapy-related acute leukaemia in mitoxantrone-treated multiple sclerosis patients in Germany

scientific article published in March 2012

Incidence, characterization, and clinical impact analysis of peginterferon beta1a immunogenicity in patients with multiple sclerosis in the ADVANCE trial

scientific article published on 10 March 2016

Induction of pro-inflammatory cytokine production in thymocytes by the immune response modifiers Imiquimod and Gardiquimod™.

scientific article published on 15 July 2013

Inflammatory Demyelinating Brain Lesions Heralding Primary CNS Lymphoma ⬇️

scientific article published on January 1, 2012

Inhibition by mitoxantrone of in vitro migration of immunocompetent cells: a possible mechanism for therapeutic efficacy in the treatment of multiple sclerosis

scientific article published in November 2006

Inhibition of Endogenous Interferon Beta by Neutralizing Antibodies Against Recombinant Interferon Beta ⬇️

scientific article published on September 1, 2010

Initial lymphocyte count and low BMI may affect fingolimod-induced lymphopenia

scientific article published on 31 October 2014

Interferon-beta and neuroprotection in multiple sclerosis--facts, hopes and phantasies

scientific article published on 25 October 2006

Interleukin 23 in acute inflammatory demyelination of the peripheral nerve

scientific article published in June 2006

Interleukin-17 impedes Schwann cell-mediated myelination

scientific article published on 29 March 2014

Intravenous immunoglobulins in the treatment of immune neuropathies

scientific article published on October 2008

Isoniazid-induced polyneuropathy in a tuberculosis patient - implication for individual risk stratification with genotyping?

scientific article published on 29 May 2015

L-selectin is a possible biomarker for individual PML risk in natalizumab-treated MS patients

scientific article published on 7 August 2013

Lack of IL-6 augments inflammatory response but decreases vascular permeability in bacterial meningitis

scientific article published on 23 June 2003

Levetiracetam exhibits protective properties on rat Schwann cells in vitro

scientific article

Long-term B-lymphocyte depletion with rituximab in patients with relapsing-remitting multiple sclerosis

scientific article published in February 2009

Long-term Therapy With Interleukin 6 Receptor Blockade in Highly Active Neuromyelitis Optica Spectrum Disorder

scientific article published on July 2015

Long-term antiepileptic treatment with histone deacetylase inhibitors may reduce the risk of prostate cancer ⬇️

scientific article published on January 1, 2012

Lysophosphatidic acid propagates post-injury Schwann cell dedifferentiation through LPA1 signaling

scientific article

Mechanisms of mitoxantrone in multiple sclerosis--what is known?

scientific article published in August 2004

Mitoxantrone (Novantrone) in multiple sclerosis: new insights

scientific article

Mitoxantrone in multiple sclerosis.

scientific article

Monocyte-derived HLA-G acts as a strong inhibitor of autologous CD4 T cell activation and is upregulated by interferon-beta in vitro and in vivo: rationale for the therapy of multiple sclerosis.

scientific article

Mouse Schwann cells activate MHC class I and II restricted T-cell responses, but require external peptide processing for MHC class II presentation

article

Multiple paradigm shifts in multiple sclerosis

scientific article

Multiple sclerosis therapy: an update on recently finished trials

scientific article published on 15 November 2007

Multiple sclerosis: Mitoxantrone promotes differential effects on immunocompetent cells in vitro

scientific article published in November 2005

Multiple sclerosis: advances, excitements, disenchantments

scientific article

Multiple sclerosis: combination therapy in MS--still a valid strategy

scientific article

Multiple sclerosis: reprogramming the immune repertoire with alemtuzumab in MS.

scientific article

Muscle-derived positive and negative regulators of the immune response

scientific article

Natalizumab affects the T-cell receptor repertoire in patients with multiple sclerosis

scientific article published on 18 September 2013

Natalizumab and impedance of the homing of CD34+ hematopoietic progenitors

scientific article

Natalizumab and progressive multifocal leukoencephalopathy: what are the causal factors and can it be avoided?

scientific article published on August 2010

Natalizumab exerts a suppressive effect on surrogates of B cell function in blood and CSF.

scientific article

Natalizumab restores aberrant miRNA expression profile in multiple sclerosis and reveals a critical role for miR-20b

scientific article

Natalizumab treatment in a patient with chronic inflammatory demyelinating polyneuropathy

scientific article published on July 2010

Neurofilament ELISA validation

scientific article published on 24 October 2009

Neuromyelitis optica following human papillomavirus vaccination

scientific article published on 20 June 2012

Neuronal ADAM10 Promotes Outgrowth of Small-Caliber Myelinated Axons in the Peripheral Nervous System

scientific article published in November 2015

Neuroprotection, regeneration and immunomodulation: broadening the therapeutic repertoire in multiple sclerosis

scientific article published on 04 January 2010

Neutralising antibodies to interferon beta in multiple sclerosis : expert panel report

scientific article published on 24 April 2007

New immunopathologic insights into multiple sclerosis ⬇️

scientific article published on May 1, 2003

No blocking effects of the pentapeptide QYNAD on Na+ channel subtypes expressed in Xenopus oocytes or action potential conduction in isolated rat sural nerve

scientific article published in December 2003

No evidence of increased oxidative degradation of urate to allantoin in the CSF and serum of patients with multiple sclerosis

scientific article

Novel pathomechanisms in inflammatory neuropathies

scientific article published on 28 November 2017

Novel treatment for immune neuropathies on the horizon ⬇️

scientific article published on June 1, 2011

Nrf2 and beyond: deciphering the mode of action of fumarates in the inflamed central nervous system

scientific article

Occurrence of Anti-Drug Antibodies against Interferon-Beta and Natalizumab in Multiple Sclerosis: A Collaborative Cohort Analysis

scientific article

Optical coherence tomography measures axonal loss in multiple sclerosis independently of optic neuritis

scientific article

Optimizing therapy early in multiple sclerosis: An evidence-based view

scientific article

Oral Tolerance Induction in Experimental Autoimmune Encephalomyelitis with Candida utilis Expressing the Immunogenic MOG35-55 Peptide

scientific article published on 9 May 2016

Oral disease-modifying treatments for multiple sclerosis: the story so far.

scientific article published on January 2007

PEG minocycline-liposomes ameliorate CNS autoimmune disease

scientific article

PEGylation of Interferon-β-1a

scientific article published on March 1, 2012

Peginterferon beta-1a improves MRI measures and increases the proportion of patients with no evidence of disease activity in relapsing-remitting multiple sclerosis: 2-year results from the ADVANCE randomized controlled trial

scientific article

Peginterferon beta-1a in multiple sclerosis: 2-year results from ADVANCE

scientific article published on 28 November 2014

Peginterferon beta-1a reduces disability worsening in relapsing-remitting multiple sclerosis: 2-year results from ADVANCE.

scientific article

Pegylated interferon β-1a for relapsing-remitting multiple sclerosis (ADVANCE): a randomised, phase 3, double-blind study

scientific article

Persistence of immunopathological and radiological traits in multiple sclerosis

scientific article published in November 2008

Pharmacokinetics and pharmacodynamics of the interferon-betas, glatiramer acetate, and mitoxantrone in multiple sclerosis

scientific article published on 27 March 2007

Pharmacological treatment of early multiple sclerosis

scientific article published on January 2008

Plasma exchange in immune-mediated neuropathies

scientific article published on October 2008

Plasma exchange in neuroimmunological disorders: Part 1: Rationale and treatment of inflammatory central nervous system disorders

scientific article published on July 2006

Plasma exchange in neuroimmunological disorders: part 2. Treatment of neuromuscular disorders

scientific article published on August 2006

Postpartum disease activity and breastfeeding in multiple sclerosis revisited

scientific article published in August 2010

Potential risk of progressive multifocal leukoencephalopathy with natalizumab therapy: possible interventions

scientific article published on February 2007

Predicting the Response to Intravenous Immunoglobulins in an Animal Model of Chronic Neuritis

scientific article

Pregnancy outcomes following maternal and paternal exposure to teriflunomide during treatment for relapsing-remitting multiple sclerosis

scientific article

Presumptive Progressive Multifocal Leukoencephalopathy in Multiple Sclerosis after Natalizumab Therapy ⬇️

scientific article published on January 16, 2013

Prion proteins: physiological functions and role in neurological disorders

scientific article published on 17 August 2007

Progress in Recognizing and Treating Polyneuropathy

scientific article

Promoting myelination in an in vitro mouse model of the peripheral nervous system: the effect of wine ingredients [corrected]

scientific article (publication date: 2013)

Pseudomonas aeruginosa and Its Bacterial Components Influence the Cytokine Response in Thymocytes and Splenocytes

scientific article published on 22 February 2016

Purely systemically active anti-inflammatory treatments are adequate to control multiple sclerosis

scientific article

Quinpramine ameliorates rat experimental autoimmune neuritis and redistributes MHC class II molecules

scientific article

Quinpramine is a novel compound effective in ameliorating brain autoimmune disease

scientific article

Quinpramine--a promising compound for treating immune-mediated demyelination of the nervous system

scientific article published on June 2010

Recent developments and future directions in Guillain‐Barré syndrome ⬇️

scientific article published on December 1, 2012

Recovery of the T-cell repertoire in CIDP by IV immunoglobulins

scientific article published on 26 December 2012

Relevance of CD34+ cells as a reservoir for JC virus in patients with multiple sclerosis

scientific article

Review of teriflunomide and its potential in the treatment of multiple sclerosis

Review of teriflunomide and its potential in the treatment of multiple sclerosis

scientific article published on 10 June 2009

Review: Innovative monoclonal antibody therapies in multiple sclerosis ⬇️

scientific article published on July 1, 2008

Review: Pathogenesis and treatment of immune-mediated neuropathies ⬇️

scientific article published on July 1, 2009

Risk stratification for progressive multifocal leukoencephalopathy in patients treated with natalizumab

scientific article published on February 2012

Rituximab as a highly effective treatment in a female adolescent with severe multiple sclerosis

scientific article published in February 2009

Role of nitric oxide as mediator of nerve injury in inflammatory neuropathies

scientific article published in April 2007

Safety and clinical outcomes of rituximab therapy in patients with different autoimmune diseases: experience from a national registry (GRAID).

scientific article published on 13 May 2011

Safety and efficacy of amiselimod in relapsing multiple sclerosis (MOMENTUM): a randomised, double-blind, placebo-controlled phase 2 trial

scientific article published on 16 August 2016

Schwann cells promote post-traumatic nerve inflammation and neuropathic pain through MHC class II.

scientific article published on 2 October 2017

Specific aspects of modern life for people with multiple sclerosis: considerations for the practitioner

scientific article published on March 2014

Subcutaneous immunoglobulins in the treatment of chronic immune-mediated neuropathies

scientific article

Subgroup and sensitivity analyses of annualized relapse rate over 2 years in the ADVANCE trial of peginterferon beta-1a in patients with relapsing-remitting multiple sclerosis

scientific article published on 17 June 2016

Successful Replication of GWAS Hits for Multiple Sclerosis in 10,000 Germans Using the Exome Array

scientific article published on 26 October 2015

Sural sparing pattern discriminates Guillain-Barré syndrome from its mimics

scientific article published on 24 September 2014

Symptomatic therapy in multiple sclerosis: a review for a multimodal approach in clinical practice

scientific article

Symptomatic therapy in multiple sclerosis: the role of cannabinoids in treating spasticity ⬇️

scientific article published on September 1, 2012

Targeting lysophospholipid signaling as a therapeutic approach towards improved peripheral nerve regeneration.

scientific article published on November 2016

Targeting two-pore domain potassium channels — A promising strategy for treating T cell mediated autoimmunity ⬇️

scientific article published on January 23, 2013

Teriflunomide for the treatment of multiple sclerosis

scientific article published on December 2013

The Role of Peripheral Myelin Protein 2 in Remyelination

scientific article published on 26 April 2017

The Wlds transgene reduces axon loss in a Charcot-Marie-Tooth disease 1A rat model and nicotinamide delays post-traumatic axonal degeneration

scientific article

The challenges of measuring disability accumulation in relapsing-remitting multiple sclerosis: evidence from interferon beta treatments

scientific article published on January 2014

The future of multiple sclerosis therapy

scientific article

The immunocompetence of Schwann cells

scientific article published on January 2008

The mechanism of action of interferon-β in relapsing multiple sclerosis

scientific article (publication date: June 2011)

The monoclonal anti-VLA-4 antibody natalizumab mobilizes CD34+ hematopoietic progenitor cells in humans

scientific article

The neonatal CNS is not conducive for encephalitogenic Th1 T cells and B cells during experimental autoimmune encephalomyelitis ⬇️

scientific article published on May 24, 2013

The prefaces of Charcot: Leitmotifs of an international career ⬇️

scientific article published on October 28, 2003

Therapeutic approaches to multiple sclerosis: an update on failed, interrupted, or inconclusive trials of immunomodulatory treatment strategies

scientific article published on August 2010

Therapeutic approaches to multiple sclerosis: an update on failed, interrupted, or inconclusive trials of neuroprotective and alternative treatment strategies

scientific article published on October 2010

Therapeutic role of mitoxantrone in multiple sclerosis

scientific article

Therapeutic strategies in the Guillain-Barré syndrome

scientific article

Therapy of immune neuropathies with intravenous immunoglobulins

scientific article published on September 2006

Tissue mRNA expression in rat of newly described matrix metalloproteinases

scientific article

Towards the implementation of 'no evidence of disease activity' in multiple sclerosis treatment: the multiple sclerosis decision model

scientific article published on January 2015

Translating new insights into treatment optimisation in multiple sclerosis

scientific article published in February 2009

Translational research in neurology and neuroscience 2010: multiple sclerosis

scientific article published on 12 July 2010

Treating neuromyelitis optica with the interleukin-6 receptor antagonist tocilizumab

scientific article published on 26 March 2014

Treatment and treatment trials in multiple sclerosis

scientific article published on June 2007

Variability in detection and quantification of interferon β-1b-induced neutralizing antibodies

scientific article published on 15 June 2012

Vestibular hypofunction after monosodium glutamate ingestion: broadening the spectrum of 'Chinese restaurant syndrome'.

scientific article published on 8 April 2016

alpha4-Integrin antagonism with natalizumab: effects and adverse effects

scientific article published on December 2008

Paulina is supported by:

About Paulina

Help